Published in J Appl Toxicol on May 28, 2014
A Zebrafish Drug-Repurposing Screen Reveals sGC-Dependent and sGC-Independent Pro-Inflammatory Activities of Nitric Oxide. PLoS One (2015) 0.78
Intersection of toxicogenomics and high throughput screening in the Tox21 program: an NIEHS perspective. Int J Biotechnol (2016) 0.77
Opposing effects of ketamine and acetyl l-carnitine on the serotonergic system of zebrafish. Neurosci Lett (2015) 0.76
Distinct effects of ketamine and acetyl l-carnitine on the dopamine system in zebrafish. Neurotoxicol Teratol (2016) 0.76
Zebrafish Embryo as an In Vivo Model for Behavioral and Pharmacological Characterization of Methylxanthine Drugs. Int J Mol Sci (2017) 0.75
Embryo and Developmental Toxicity of Cefazolin Sodium Impurities in Zebrafish. Front Pharmacol (2017) 0.75
Determinants of low birth weight: methodological assessment and meta-analysis. Bull World Health Organ (1987) 16.26
The identification of genes with unique and essential functions in the development of the zebrafish, Danio rerio. Development (1996) 8.87
Recognition of the fetal alcohol syndrome in early infancy. Lancet (1973) 8.57
Pattern of malformation in offspring of chronic alcoholic mothers. Lancet (1973) 7.45
In vivo drug discovery in the zebrafish. Nat Rev Drug Discov (2005) 6.56
The behaviour and ecology of the zebrafish, Danio rerio. Biol Rev Camb Philos Soc (2007) 4.11
Intrauterine growth and gestational duration determinants. Pediatrics (1987) 3.68
Zebrafish comparative genomics and the origins of vertebrate chromosomes. Genome Res (2000) 3.50
Effect of maternal cigarette smoking on pregnancy complications and sudden infant death syndrome. J Fam Pract (1995) 3.23
Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci (2005) 3.08
Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science (1989) 2.77
Ketamine: teaching an old drug new tricks. Anesth Analg (1998) 2.35
Neuromuscular synapses can form in vivo by incorporation of initially aneural postsynaptic specializations. Development (2005) 2.30
Sensorimotor gating in larval zebrafish. J Neurosci (2007) 2.25
Ethanol effects on the developing zebrafish: neurobehavior and skeletal morphogenesis. Neurotoxicol Teratol (2004) 2.24
Maternal caffeine intake during pregnancy is associated with birth weight but not with gestational length: results from a large prospective observational cohort study. BMC Med (2013) 2.20
Automated image-based phenotypic analysis in zebrafish embryos. Dev Dyn (2009) 2.11
Zebrafish: an emerging model system for human disease and drug discovery. Clin Pharmacol Ther (2007) 1.89
The state of the art of the zebrafish model for toxicology and toxicologic pathology research--advantages and current limitations. Toxicol Pathol (2003) 1.79
Acute effects of alcohol on larval zebrafish: a genetic system for large-scale screening. Pharmacol Biochem Behav (2004) 1.75
Ketamine. Handb Exp Pharmacol (2008) 1.72
Spatial and temporal regulation of ventral spinal cord precursor specification by Hedgehog signaling. Development (2004) 1.62
Zebrafish-based small molecule discovery. Chem Biol (2003) 1.53
Ethanol exposure alters zebrafish development: a novel model of fetal alcohol syndrome. Neurotoxicol Teratol (2004) 1.48
FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation. PLoS One (2009) 1.48
Animal model systems for the study of alcohol teratology. Exp Biol Med (Maywood) (2005) 1.47
Zebrafish development and regeneration: new tools for biomedical research. Int J Dev Biol (2009) 1.46
Teratogenic effects of ethanol exposure on zebrafish visual system development. Neurotoxicol Teratol (2006) 1.44
Prenatal alcohol exposure: comparability of effects in humans and animal models. Neurotoxicol Teratol (1990) 1.43
Prenatal exposure to tobacco: II. Effects on cognitive functioning at age three. Int J Epidemiol (1990) 1.40
Zebrafish as a new model for phenotype-based screening of melanogenic regulatory compounds. Pigment Cell Res (2007) 1.40
Zebrafish as a pharmacological tool: the how, why and when. Curr Opin Pharmacol (2004) 1.35
Induction of cytochrome P450 1A is required for circulation failure and edema by 2,3,7,8-tetrachlorodibenzo-p-dioxin in zebrafish. Biochem Biophys Res Commun (2003) 1.34
Intellectual impairment in children of women who smoke cigarettes during pregnancy. Pediatrics (1994) 1.30
Small molecule screening in the zebrafish. Methods (2006) 1.28
Strategies and experimental models for evaluating anesthetics: effects on the developing nervous system. Anesth Analg (2008) 1.23
Regulation of motor neuron subtype identity by repressor activity of Mnx class homeodomain proteins. Development (2003) 1.23
Ethanol-dependent toxicity in zebrafish is partially attenuated by antioxidants. Neurotoxicol Teratol (2006) 1.21
DarT: The embryo test with the Zebrafish Danio rerio--a general model in ecotoxicology and toxicology. ALTEX (2002) 1.17
Zebrafish and fly Nkx6 proteins have similar CNS expression patterns and regulate motoneuron formation. Development (2004) 1.15
Maternal periconceptional smoking and alcohol consumption and risk for select congenital anomalies. Birth Defects Res A Clin Mol Teratol (2008) 1.15
Maternal periconceptional alcohol consumption and risk of orofacial clefts. Am J Epidemiol (2007) 1.13
Development of a zebrafish embryo teratogenicity assay and quantitative prediction model. Birth Defects Res B Dev Reprod Toxicol (2010) 1.12
Evaluation of the reproductive and developmental risks of caffeine. Birth Defects Res B Dev Reprod Toxicol (2011) 1.10
Development of a screening assay to identify teratogenic and embryotoxic chemicals using the zebrafish embryo. Reprod Toxicol (2009) 1.10
Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening. J Am Chem Soc (2003) 1.07
Zebrafish models to study drug abuse-related phenotypes. Rev Neurosci (2011) 1.05
Effects of ethanol on photoreceptors and visual function in developing zebrafish. Invest Ophthalmol Vis Sci (2006) 1.05
Human pharmaceuticals in the aquatic environment: a challenge to Green Chemistry. Chem Rev (2007) 1.03
Effects of temperature on the deformity and sex differentiation of tilapia, Oreochromis mossambicus. J Exp Zool (2000) 1.03
Neurotoxicity assessment using zebrafish. J Pharmacol Toxicol Methods (2007) 1.02
Fishing for genes controlling development. Curr Opin Genet Dev (1996) 1.01
Caffeine. Annu Rev Nutr (1982) 0.99
Zebrafish embryos exposed to alcohol undergo abnormal development of motor neurons and muscle fibers. Neurotoxicol Teratol (2010) 0.97
Developmental neurotoxicity of ketamine in pediatric clinical use. Toxicol Lett (2013) 0.96
Effects of aging on acute toxicity of nicotine in rats. Pharmacol Toxicol (1994) 0.95
Chemical genetics suggests a critical role for lysyl oxidase in zebrafish notochord morphogenesis. Mol Biosyst (2006) 0.95
Ocular deficits associated with alcohol exposure during zebrafish development. J Comp Neurol (2007) 0.94
High-content screening assay for identification of chemicals impacting spontaneous activity in zebrafish embryos. Environ Sci Technol (2013) 0.94
The zebrafish as a model system to study cardiovascular development. Trends Cardiovasc Med (2011) 0.94
High-content screening assay for identification of chemicals impacting cardiovascular function in zebrafish embryos. Environ Sci Technol (2013) 0.94
The zebrafish: heritable disorders in transparent embryos. J Clin Invest (1996) 0.93
Development of a flow-through system for the fish embryo toxicity test (FET) with the zebrafish (Danio rerio). Toxicol In Vitro (2009) 0.92
Toxicity of lindane, atrazine, and deltamethrin to early life stages of zebrafish (Brachydanio rerio). Ecotoxicol Environ Saf (1990) 0.90
Fish embryo toxicity of carbamazepine, diclofenac and metoprolol. Ecotoxicol Environ Saf (2010) 0.90
Metabolic rate of Arctic charr eggs depends on their parentage. J Comp Physiol B (2005) 0.89
Plasma levels of nicotine and safety of smokers wearing transdermal delivery systems during multiple simultaneous intake of nicotine and during exercise. J Clin Pharmacol (1997) 0.88
Movement disorder and neuromuscular change in zebrafish embryos after exposure to caffeine. Neurotoxicol Teratol (2008) 0.88
Low concentrations of ketamine initiate dendritic atrophy of differentiated GABAergic neurons in culture. Toxicology (2007) 0.86
Congenital malformations in offspring of mice treated with caffeine. Proc Soc Exp Biol Med (1960) 0.86
Identification of the F1F0 mitochondrial ATPase as a target for modulating skin pigmentation by screening a tagged triazine library in zebrafish. Mol Biosyst (2005) 0.84
Zebrafish model in drug safety assessment. Curr Pharm Des (2014) 0.83
Maternal consumption of coffee and caffeine-containing beverages and oral clefts: a population-based case-control study in Norway. Am J Epidemiol (2009) 0.83
Nicotine-induced antinociception in mice: role of G-proteins and adenylate cyclase. Pharmacol Biochem Behav (1994) 0.82
In vivo imaging and quantitative analysis of changes in axon length using transgenic zebrafish embryos. Neurotoxicol Teratol (2011) 0.82
Caffeine-induced effects on heart rate in zebrafish embryos and possible mechanisms of action: an effective system for experiments in chemical biology. Zebrafish (2010) 0.82
Acetyl L-carnitine protects motor neurons and Rohon-Beard sensory neurons against ketamine-induced neurotoxicity in zebrafish embryos. Neurotoxicol Teratol (2013) 0.82
A panel of biological tests reveals developmental effects of pharmaceutical pollutants on late stage zebrafish embryos. Reprod Toxicol (2012) 0.82
From omics to drug metabolism and high content screen of natural product in zebrafish: a new model for discovery of neuroactive compound. Evid Based Complement Alternat Med (2012) 0.81
Alcohol use in pregnancy: insights in screening and intervention for the clinician. Clin Obstet Gynecol (2013) 0.81
Infant with in utero ketamine exposure: quantitative measurement of residual dosage in hair. Pediatr Neonatol (2010) 0.81
Relative embryotoxicity of two classes of chemicals in a modified zebrafish embryotoxicity test and comparison with their in vivo potencies. Toxicol In Vitro (2011) 0.81
Small molecule modifier screen for kit-dependent functions in zebrafish embryonic melanocytes. Zebrafish (2008) 0.81
Ketamine NMDA receptor-independent toxicity during zebrafish (Danio rerio) embryonic development. Neurotoxicol Teratol (2013) 0.81
L-Carnitine rescues ketamine-induced attenuated heart rate and MAPK (ERK) activity in zebrafish embryos. Reprod Toxicol (2011) 0.81
Long-term age-dependent behavioral changes following a single episode of fetal N-methyl-D-Aspartate (NMDA) receptor blockade. BMC Pharmacol (2004) 0.80
Parental effects on embryonic viability and growth in Arctic charr Salvelinus alpinus at two incubation temperatures. J Fish Biol (2010) 0.80
Zebrafish developmental toxicity assay: A fishy solution to reproductive toxicity screening, or just a red herring? Reprod Toxicol (2011) 0.80
Pollutants as developmental toxicants in aquatic organisms. Environ Health Perspect (1987) 0.80
Ketamine attenuates cytochrome p450 aromatase gene expression and estradiol-17β levels in zebrafish early life stages. J Appl Toxicol (2013) 0.80
Thermally induced phenotypic plasticity of swimming performance in European sea bass Dicentrarchus labrax juveniles. J Fish Biol (2009) 0.79
Effect of temperature on muscle lactate metabolic recovery in sea bass (Dicentrarchus labrax, L.) juveniles exposed to exhaustive exercise. Fish Physiol Biochem (2009) 0.79
Relationships between moderate maternal alcohol consumption during pregnancy and infant neurological development. J Stud Alcohol (1983) 0.79
Neural tube defects caused by local anesthetics in early chick embryos. Teratology (1985) 0.78
Effect of caffeine on rat offspring from treated dams. Toxicol Lett (1980) 0.78
Excitatory amino acids: modes of action on hippocampal pyramidal cells. Fed Proc (1983) 0.78
Inter-laboratory assessment of a harmonized zebrafish developmental toxicology assay - progress report on phase I. Reprod Toxicol (2011) 0.78
Effects of co-administration of bupropion and nicotine or D-amphetamine on the elevated plus maze test in mice. J Pharm Pharmacol (2009) 0.76
Chemical class-specific gene expression changes in the zebrafish embryo after exposure to glycol ether alkoxy acids and 1,2,4-triazole antifungals. Reprod Toxicol (2011) 0.75
Toxicity of cadmium-contaminated clay to the zebrafish Danio rerio. Arch Environ Contam Toxicol (2000) 0.75
Ketamine-induced neuronal cell death in the perinatal rhesus monkey. Toxicol Sci (2007) 3.22
Cytotoxicity effects of graphene and single-wall carbon nanotubes in neural phaeochromocytoma-derived PC12 cells. ACS Nano (2010) 2.05
Prolonged exposure to ketamine increases neurodegeneration in the developing monkey brain. Int J Dev Neurosci (2009) 1.76
The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci (2006) 1.55
Novel regulation of parkin function through c-Abl-mediated tyrosine phosphorylation: implications for Parkinson's disease. J Neurosci (2011) 1.45
CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis. Clin Cancer Res (2010) 1.42
Neuroprotective effect of dextromethorphan in the MPTP Parkinson's disease model: role of NADPH oxidase. FASEB J (2004) 1.40
Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci (2010) 1.35
Potential neurotoxicity of ketamine in the developing rat brain. Toxicol Sci (2009) 1.33
Aurora kinase A promotes ovarian tumorigenesis through dysregulation of the cell cycle and suppression of BRCA2. Clin Cancer Res (2010) 1.31
Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals. Circ Cardiovasc Qual Outcomes (2013) 1.31
Inhalation anesthetic-induced neuronal damage in the developing rhesus monkey. Neurotoxicol Teratol (2011) 1.30
CD133 expression associated with poor prognosis in ovarian cancer. Mod Pathol (2011) 1.30
Methamphetamine-induced dopaminergic neurotoxicity in mice: long-lasting sensitization to the locomotor stimulation and desensitization to the rewarding effects of methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry (2002) 1.26
Blockade of N-methyl-D-aspartate receptors by ketamine produces loss of postnatal day 3 monkey frontal cortical neurons in culture. Toxicol Sci (2006) 1.24
Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra. Neurosci Lett (2002) 1.23
Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease. J Immunol (2008) 1.18
Cdk5 Modulation of mitogen-activated protein kinase signaling regulates neuronal survival. Mol Biol Cell (2006) 1.16
Ontogeny of the N-methyl-D-aspartate (NMDA) receptor system and susceptibility to neurotoxicity. Toxicol Sci (2002) 1.15
Expression changes of dopaminergic system-related genes in PC12 cells induced by manganese, silver, or copper nanoparticles. Neurotoxicology (2009) 1.14
Alterations in blood-brain barrier function by morphine and methamphetamine. Ann N Y Acad Sci (2006) 1.13
Influence of nanoparticles on blood-brain barrier permeability and brain edema formation in rats. Acta Neurochir Suppl (2010) 1.11
Copper nanoparticles exert size and concentration dependent toxicity on somatosensory neurons of rat. Nanotoxicology (2010) 1.08
Role of nitric oxide in rotenone-induced nigro-striatal injury. J Neurochem (2003) 1.03
Mechanistic toxicity evaluation of uncoated and PEGylated single-walled carbon nanotubes in neuronal PC12 cells. ACS Nano (2011) 1.03
Behavioral consequences of methamphetamine-induced neurotoxicity in mice: relevance to the psychopathology of methamphetamine addiction. Ann N Y Acad Sci (2002) 1.03
AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma. Mod Pathol (2011) 1.02
Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury. Ann N Y Acad Sci (2008) 1.02
Effects of 45-nm silver nanoparticles on coronary endothelial cells and isolated rat aortic rings. Toxicol Lett (2009) 1.02
Knowledge, perceptions and myths regarding infertility among selected adult population in Pakistan: a cross-sectional study. BMC Public Health (2011) 1.00
Identification of rat hippocampal mRNAs altered by the mitochondrial toxicant, 3-NPA. Ann N Y Acad Sci (2005) 1.00
Pharmacological and neurotoxicological actions mediated by bupropion and diethylpropion. Int Rev Neurobiol (2009) 0.99
Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts. Neoplasia (2013) 0.98
Influence of engineered nanoparticles from metals on the blood-brain barrier permeability, cerebral blood flow, brain edema and neurotoxicity. An experimental study in the rat and mice using biochemical and morphological approaches. J Nanosci Nanotechnol (2009) 0.98
Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats. Int J Dev Neurosci (2004) 0.98
Neuroprotective efficacy of a new brain-penetrating C-Abl inhibitor in a murine Parkinson's disease model. PLoS One (2013) 0.97
Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51. Curr Pharm Des (2007) 0.97
Improving door-to-needle times: a single center validation of the target stroke hypothesis. Stroke (2014) 0.96
Novel in Vitro Model for Keratoconus Disease. J Funct Biomater (2012) 0.96
Metabonomic study on chronic unpredictable mild stress and intervention effects of Xiaoyaosan in rats using gas chromatography coupled with mass spectrometry. J Ethnopharmacol (2011) 0.96
Protective effects of 7-nitroindazole on ketamine-induced neurotoxicity in rat forebrain culture. Neurotoxicology (2008) 0.96
Differential effects of amphetamines-induced neurotoxicity on appetitive and aversive Pavlovian conditioning in mice. Neuropsychopharmacology (2005) 0.96
-251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case-control studies. Mol Biol Rep (2011) 0.95
A minimally invasive, translational biomarker of ketamine-induced neuronal death in rats: microPET Imaging using 18F-annexin V. Toxicol Sci (2009) 0.94
Interleukin-8-251A/T polymorphism and Helicobacter pylori infection influence risk for the development of gastric cardiac adenocarcinoma in a high-incidence area of China. Mol Biol Rep (2010) 0.93
Peroxynitrite and the regulation of Na(+),K(+)-ATPase activity by angiotensin II in the rat proximal tubule. Nitric Oxide (2002) 0.93
Ketamine-induced neuronal damage and altered N-methyl-D-aspartate receptor function in rat primary forebrain culture. Toxicol Sci (2012) 0.93
A pilot study of preemptive morphine analgesia in preterm neonates: effects on head circumference, social behavior, and response latencies in early childhood. Neurotoxicol Teratol (2011) 0.92
Ketamine-induced neurotoxicity and changes in gene expression in the developing rat brain. Curr Neuropharmacol (2011) 0.92
Receptor for AGEs (RAGE) as mediator of NF-kB pathway activation in neuroinflammation and oxidative stress. CNS Neurol Disord Drug Targets (2014) 0.92
Cell cycle regulators at the ocular surface. Exp Eye Res (2004) 0.91
Silver nanoparticle-induced mutations and oxidative stress in mouse lymphoma cells. Environ Mol Mutagen (2012) 0.91
Effect of methylphenidate on time perception in children with attention-deficit/hyperactivity disorder. Exp Clin Psychopharmacol (2004) 0.91
Distribution and systemic effects of intranasally administered 25 nm silver nanoparticles in adult mice. Toxicol Pathol (2012) 0.91
Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice. FASEB J (2005) 0.91
The potentiating effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on paraquat-induced neurochemical and behavioral changes in mice. Pharmacol Biochem Behav (2006) 0.90
Preclinical evaluation of GBR12909 decanoate as a long-acting medication for methamphetamine dependence. Ann N Y Acad Sci (2002) 0.90
A microarray study of MPP+-treated PC12 Cells: Mechanisms of toxicity (MOT) analysis using bioinformatics tools. BMC Bioinformatics (2005) 0.90
Plasma levels of parent compound and metabolites after doses of either d-fenfluramine or d-3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations. Neurotoxicology (2003) 0.90
β2-adrenergic receptor activation prevents rodent dopaminergic neurotoxicity by inhibiting microglia via a novel signaling pathway. J Immunol (2011) 0.89
Developmental aspects of timing behavior in children. Neurotoxicol Teratol (2004) 0.89
Developmental origins of adult diseases and neurotoxicity: epidemiological and experimental studies. Neurotoxicology (2012) 0.89
Excitotoxic damage, disrupted energy metabolism, and oxidative stress in the rat brain: antioxidant and neuroprotective effects of L-carnitine. J Neurochem (2008) 0.88
Preclinical assessment of ketamine. CNS Neurosci Ther (2013) 0.88
Comparative effects of substituted amphetamines (PMA, MDMA, and METH) on monoamines in rat caudate: a microdialysis study. Ann N Y Acad Sci (2002) 0.88
Repeated administration of gamma-hydroxybutyric acid (GHB) to mice: assessment of the sedative and rewarding effects of GHB. Ann N Y Acad Sci (2002) 0.88
Disorganized collagen scaffold interferes with fibroblast mediated deposition of organized extracellular matrix in vitro. Biotechnol Bioeng (2012) 0.88
Anesthetic-induced oxidative stress and potential protection. ScientificWorldJournal (2010) 0.88
The genotoxicity of acrylamide and glycidamide in big blue rats. Toxicol Sci (2010) 0.88
Neural effects of MDMA as determined by functional magnetic resonance imaging and magnetic resonance spectroscopy in awake marmoset monkeys. Ann N Y Acad Sci (2006) 0.87
Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures, and the blood-brain barrier. Ann N Y Acad Sci (2008) 0.87
Baseline behavior, but not sensitivity to stimulant drugs, differs among spontaneously hypertensive, Wistar-Kyoto, and Sprague-Dawley rat strains. Neurotoxicol Teratol (2007) 0.87
Acute administration of cocaine regulates the phosphorylation of serine-19, -31 and -40 in tyrosine hydroxylase. J Neurochem (2002) 0.87
Female mini-pig performance of temporal response differentiation, incremental repeated acquisition, and progressive ratio operant tasks. Behav Processes (2008) 0.87
Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsin-D in methamphetamine-induced apoptotic cell death. Ann N Y Acad Sci (2006) 0.87
Systems biology approaches for toxicology. J Appl Toxicol (2007) 0.87
The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice. J Neurochem (2009) 0.86
Neuroprotective strategies in drug abuse-evoked encephalopathy. Ann N Y Acad Sci (2010) 0.86
The genetic toxicology of methylphenidate hydrochloride in non-human primates. Mutat Res (2008) 0.86
Metabolic syndrome in drug abuse. Ann N Y Acad Sci (2007) 0.86
Role of mitochondrial dysfunction in neurotoxicity of MPP+: partial protection of PC12 cells by acetyl-L-carnitine. Ann N Y Acad Sci (2004) 0.86
Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies. J Neurochem (2003) 0.86
Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen. Synapse (2006) 0.86
Retracted S-allyl cysteine protects against 6-hydroxydopamine-induced neurotoxicity in the rat striatum: involvement of Nrf2 transcription factor activation and modulation of signaling kinase cascades. Free Radic Biol Med (2012) 0.86
Cocaine induces a differential dose-dependent alteration in the expression profile of immediate early genes, transcription factors, and caspases in PC12 cells: a possible mechanism of neurotoxic damage in cocaine addiction. Ann N Y Acad Sci (2005) 0.86
6-OHDA-induced apoptosis and mitochondrial dysfunction are mediated by early modulation of intracellular signals and interaction of Nrf2 and NF-κB factors. Toxicology (2012) 0.85
Effect of pair-housing on operant behavior task performance by rhesus monkeys. Contemp Top Lab Anim Sci (2003) 0.84
Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram. Neuropsychopharmacology (2007) 0.84